FDA applicant
Senseonics, Incorporated
FDA records 3 decisions for Senseonics, Incorporated (Germantown, MD) from 2018 to 2024: 1 510(k) clearance, 1 De Novo grant and 1 original PMA approval. Most are in product codes SBA (Integrated Continuous Glucose Monitoring…) and QCD (Continuous Glucose Monitor, Implanted…). Its devices cite 1 predicate, 1 of them its own earlier devices. 1 recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Senseonics, Incorporated’s devices, and how often a recall has named them.
FDA decisions per year
2in 2024
2026 so far, outlined.
Recalls per year
1in 2019
Class I Class II/III not classified
Planning a device like Senseonics, Incorporated’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report